Clinical Trials Browser

Phase 2 × Terminated × erdafitinib × Clear all

NCT04754425 2026-02-06

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT03827850 2023-06-09

FIND

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02952573 2020-09-17

Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement

Phase 2 Terminated

Multiple Myeloma, Recurrence